Russian Federation
Russian Federation
from 01.01.2021 until now
Russian Federation
Russian Federation
UDK 50 Общие вопросы математических и естественных наук
UDK 61 Медицина. Охрана здоровья. Пожарное дело
According to the literature, true erosion occurs in no more than 2% of cases, however, the term "erosion" is used by patients, and often by clinicians, to replace another condition – ectopia, which is already significantly widespread: it is found when examined in mirrors in 38.8% of the female population [1,2]. Cervical erosion is a violation of the integrity of the epithelial cover of the vaginal part of the cervix. The disease has a benign course, but is the pathophysiological basis for the easy introduction of HPV into the exposed basal cells of the epithelial layer, which can subsequently lead to precancerous and cervical cancer. Erosion is a consequence of mechanical damage to a healthy epithelium (careless insertion of a mirror, rough sexual intercourse, sex toys) or, which is significantly more common, compromised by an inflammatory process, oncology or vulvovaginal atrophy. As is known, the damaged mucous membrane of the cervix, which already does not have a barrier cornea even in a healthy state, is vulnerable to the development of the infectious process. Ectopia is a physiological process, and, according to modern concepts, does not require treatment. However, it is proven that HPV infection is more likely in the presence of ectopia [1]. HPV entering the body of a woman with pre-existing erosive changes or the physiological state of the presence of a cylindrical epithelium on the surface of the exocervix of the cervix can lead to adverse consequences.
Erosion, ectopia, cervix, histology, pathological anatomy, HPV
1. Farhan Tarek, Fahrutdinova E.H. Patologiya sheyki matki i profilaktika raka shey-ki matki: aktual'nye podhody i strategii. Mezhdunarodnyy nauchnyy zhurnal «VESTNIK NAUKI» № 4.2023;61(3): 344 - 354. Elektronnyy resurs https://www.vestnik-nauki.rf/article/7814.
2. Dzh. Degenhard. Prognoz rasprostranennosti kureniya sredi zhenschin v Rossii na 2001–2029 gody. 30 yanvarya 2024 g. URL: https://www.statista.com
3. Bull, F. C., Al-Ansari, S. S., Biddle, S., Borodulin, K., Buman, M. P., Cardon, G., Carty, C., Chaput, J. P., Chastin, S., Chou, R., Dempsey, P. C., DiPietro, L., Ekelund, U., Firth, J., Friedenreich, C. M., Garcia, L., Gichu, M., Jago, R., Katzmarzyk, P. T., Lambert, E., … Wil-lumsen, J. F. (2020). World Health Organization 2020 guidelines on physical activity and sed-entary behaviour. British journal of sports medicine, 54(24), 1451–1462. https://doi.org/10.1136/bjsports-2020-102955
4. O.A. Sharshova, Yu.V. Grigor'eva, uchebnoe posobie – Blagoveschensk: 2019, 102 s.
5. Rebeca Schiller. Cervical Cancer Survival Rate: What to Expect. August 16, 2024. URL: https://www.verywellhealth.com
6. Amerikanskoe onkologicheskoe obschestvo. Fakty i cifry o rake na 2024 god. Atlanta: Amerikanskoe onkologicheskoe obschestvo; 2024.
7. Navarro, S., Abla, H., Delgado, B. et al. Glycogen availability and pH variation in a medi-umsimulating vaginal fluid influence the growth of vaginal Lactobacillus species and Gardnerella vaginalis. BMC Microbiol 23, 186 (2023). https://doi.org/10.1186/s12866-023-02916-8
8. Elektronnaya biblioteka INVITRO [Elektronnyy resurs] // invitro.ru: URL: https://www.invitro.ru/library/labdiagnostika/24559/
9. [Elektronnyy resurs] // elevit.ru: URL: https://www.elevit.ru/library/zdorove-vo-vremya-beremenosti/hormones/
10. Lebedinskiy K.M., Garusova E.G., Gorban' I.V. i dr. Erozii sheyki matki: sovremen-nye podhody k diagnostike i lecheniyu. Akusherstvo i ginekologiya. 2017;7:30-35.
11. Kravcova E.A., Cyganov M.M., Litvyakov N.V., Ibragimova M.K. VPCh-associirovannyy rak sheyki matki: sovremennoe sostoyanie i perspektivy. Acta Biomedica Scientifica. 2023;8(3):42-54. https://doi.org/10.29413/ABS.2023-8.3.4
12. Luria L, Cardoza-Favarato G. Human Papillomavirus. In: StatPearls. Treasure Island (FL): StatPearls Publishing; January 16, 2023.
13. Skorstengaard M, Lynge E, Napolitano G, Blaakær J, Bor P. Risk of precancerous cervical lesions in women using a hormone-containing intrauterine device and other contraceptives: a register-based cohort study from Denmark. Hum Reprod. 2021;36(7):1796-1807. https://doi.org/10.1093/humrep/deab066.
14. Mironova V.G., Petrov Yu.A., Ermolova N.V. Onkologicheskie riski pri vnutrimatoch-noy kontracepcii. Glavvrach Yuga Rossii. 2021; 5 (80).URL: https://cyberleninka.ru/article/n/onkologicheskie-riski-pri-vnutrimatochnoy-kontratseptsii.
15. Stelzle D, Tanaka LF, Lee KK, et al. Estimates of the global burden of cervical cancer associ-ated with HIV [published correction appears in Lancet Glob Health. 2021 Feb;9(2):e119. doi:https://doi.org/10.1016/S2214-109X(20)30509-X]. Lancet Glob Health. 2021;9(2):e161-e169. https://doi.org/10.1016/S2214-109X(20)30459-9.
16. Enyan, N.I.E., Akaba, S. & Amoo, S.A. Women diagnosed with HIV and unknown HIV sta-tus perceived susceptibility to cervical cancer and perceived benefits of cervical cancer screen-ing in Ghana: a cross-sectional study. BMC Women's Health 21, 367 (2021). https://doi.org/10.1186/s12905-021-01509-9.
17. Dryden-Peterson S, Bvochora-Nsingo M, Suneja G, et al. HIV Infection and Survival Among Women With Cervical Cancer. J Clin Oncol. 2016;34(31):3749-3757. https://doi.org/10.1200/JCO.2016.67.9613
18. Bukato, K., Kostrzewa, T., Gammazza, A. M., Gorska-Ponikowska, M., & Sawicki, S. (2024). Endogenous estrogen metabolites as oxidative stress mediators and endometrial cancer bi-omarkers. Cell communication and signaling : CCS, 22(1), 205. https://doi.org/10.1186/s12964-024-01583-0
19. Doklinicheskoe issledovanie vliyaniya novoy farmacevticheskoy kompozicii na osnove 3,3'-diindolilmetana na reproduktivnuyu funkciyu i immunnuyu sistemu"// Vestnik RNCRR M3 RF, 2013, No 13, s.17.
20. Webster, K., Taylor, A., & Gaston, K. (2001). Oestrogen and progesterone increase the levels of apoptosis induced by the human papillomavirus type 16 E2 and E7 proteins. The Journal of general virology, 82(Pt 1), 201–213. https://doi.org/10.1099/0022-1317-82-1-201
21. Uzhegova Zh.A., Grigoryan O.R., Andreeva E.N. Endokrinnye aspekty patogeneza raka sheyki matki. Novye vozmozhnosti pervichnoy profilaktiki. Problemy Endokrino-logii. 2009;55(3):48-53. https://doi.org/10.14341/probl200955348-53
22. Steven C. Moore, Charles E. Matthews, Xiao Ou Shu, Kai Yu, Mitchell H. Gail, Xia Xu, Bu-Tian Ji, Wong-Ho Chow, Qiuyin Cai, Honglan Li, Gong Yang, David Ruggieri, Jennifer Boyd-Morin, Nathaniel Rothman, Robert N. Hoover, Yu-Tang Gao, Wei Zheng, Regina G. Ziegler, Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women, JNCI: Journal of the National Cancer Institute, Volume 108, Issue 10, Octo-ber 2016, djw103, https://doi.org/10.1093/jnci/djw103
23. Zi-Wei Zhou, Hui-Zhi Long, Yan Cheng, Hong-Yu Luo, Dan-Dan Wen and Li-Chen Gao. Front. Microbiol. 2021. Microbial Immunology Volume 12 - 2021. https://doi.org/10.3389/fmicb.2021.767931
24. Ming Wu1, Huanrong Li, Hongfei Yu, Ye Yan, Chen Wang, Fei Teng, Aiping Fan and Fengxia Xue. Front. Oncol., 12 July 2022 Sec. Gynecological Oncology Volume 12 - 2022 | https://doi.org/10.3389/fonc.2022.941741
25. Shen, Y., Xia, J., Li, H. et al. Human papillomavirus infection rate, distribution characteristics, and risk of age in pre- and postmenopausal women. BMC Women's Health 21, 80 (2021). https://doi.org/10.1186/s12905-021-01217-4
26. Yin, X., Zhang, C., Wu, X. et al. HPV prevalence and distribution characteristics in postmeno-pausal women from Nanjing, China. BMC Women's Health 24, 68 (2024). https://doi.org/10.1186/s12905-024-02904-8
27. Bovo, A. C., Pedrão, P. G., Guimarães, Y. M., Godoy, L. R., Resende, J. C. P., Longatto-Filho, A., & Reis, R. D. (2023). Combined Oral Contraceptive Use and the Risk of Cervical Cancer: Literature Review. Uso de anticoncepcional oral combinado e o risco de câncer cervi-cal: Revisão da literatura. Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 45(12), e818–e824. https://doi.org/10.1055/s-0043-1776403
28. Gadducci, A., Cosio, S., & Fruzzetti, F. (2020). Estro-progestin Contraceptives and Risk of Cervical Cancer: A Debated Issue. Anticancer research, 40(11), 5995–6002. https://doi.org/10.21873/anticanres.14620
29. Guo C, Zhan B, Li M-Y, Yue L and Zhang C (2024), Association between oral contraceptives and cervical cancer: A retrospective case–control study based on the National Health and Nu-trition Examination Survey. Front. Pharmacol. 15:1400667. doi:https://doi.org/10.3389/fphar.2024.1400667
30. Anastasiou, E., McCarthy, K. J., Gollub, E. L., Ralph, L., van de Wijgert, J. H. H. M., & Jones, H. E. (2022). The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review. Contraception, 107, 1–9. https://doi.org/10.1016/j.contraception.2021.10.018
31. Zaharov I.S., Shmidt A.A., Pronskiy I.A., Beskrovnyy S.V., Abashin V.G. Gormonal'-naya kontracepciya i rak sheyki matki: imeetsya li kakaya-to svyaz'? Klinicheskaya medi-cina. 2023;101(4–5):194–97. doi: http://doi.org/10.30629/0023-2149-2023-101-4-5-194-197
32. Klinicheskie rekomendacii «Cervikal'naya intraepitelial'naya neoplaziya, eroziya i ektropion sheyki matki»
33. Almeida AM, Queiroz JA, Sousa F, Sousa Â. Cervical cancer and HPV infection: Ongoing therapeutic research to counteract the action of E6 and E7 oncoproteins. Drug Discov Today. 2019; 24(10): 2044-2057. https://doi.org/10.1016/j.drudis.2019.07.011.] [Li M, Du X, Lu M, Zhang W, Sun Z, Li L, et al. Prevalence characteristics of single and multiple HPV infections in women with cervical cancer and precancerous lesions in Beijing, China. J Med Virol. 2019; 91(3): 473-481. https://doi.org/10.1002/jmv.25331
34. Shen, Y., Xia, J., Li, H. et al. Human papillomavirus infection rate, distribution characteristics, and risk of age in pre- and postmenopausal women. BMC Women's Health 21, 80 (2021). https://doi.org/10.1186/s12905-021-01217-4
35. Zaydieva Ya.Z. Menopauzal'naya gormonoterapiya i onkologicheskie riski organov re-produktivnoy sistemy. Obzor literatury. Medicinskiy alfavit. 2019;1(1):42-50. https://doi.org/10.33667/2078-5631-2019-1-1(376)-42-50
36. Garbuzova V.Yu., Knyazhev B.A. Erozii sheyki matki: klinicheskie osobennosti i podho-dy k lecheniyu. Sibirskiy medicinskiy zhurnal. 2019;129(5):51-56.
37. D'yakova I.V., Barbach O.A. Erozii sheyki matki: sovremennye aspekty diagnostiki i lecheniya. Rossiyskiy vestnik akushera-ginekologa. 2018;18(4):63-68.
38. Kvant K.A., Borisova O.A., Shumilova I.V. i dr. Erozii sheyki matki: klassifikaciya, patogenez i diagnostika. Aktual'nye problemy ginekologii, akusherstva i perinato-logii. 2020;18(3):143-149.
39. Kleschukov N.S. Erozii sheyki matki: etiologiya, patogenez i lechenie. Materialy X Vserossiyskogo kongressa akusherov-ginekologov. Chast' III. Moskva. 2016;3:63-68.
